0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Haematology

Buy Now

Chronic Lymphocytic Leukemia - Molecular Genetics, Biology, Diagnosis, and Management (Hardcover, 2004 ed.) Loot Price: R4,517
Discovery Miles 45 170
Chronic Lymphocytic Leukemia - Molecular Genetics, Biology, Diagnosis, and Management (Hardcover, 2004 ed.): Guy B. Faguet

Chronic Lymphocytic Leukemia - Molecular Genetics, Biology, Diagnosis, and Management (Hardcover, 2004 ed.)

Guy B. Faguet

Series: Contemporary Hematology

 (sign in to rate)
Loot Price R4,517 Discovery Miles 45 170 | Repayment Terms: R423 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

A comprehensive and critical review of the latest scientific advances in our understanding of the molecular genetics and biology of CLL and their application to the best management of CLL. The authors focus on diagnosis, prognosis, multifaceted treatment options, and complications. Among the diverse treatments considered are chemotherapy, autologous and allogenic transplantations, monoclonal antibody therapy, immunotoxin therapy, gene therapy, and several new therapeutic strategies. Familial and juvenile chronic lymphocytic leukemia are also discussed.

General

Imprint: HumanaPress
Country of origin: United States
Series: Contemporary Hematology
Release date: November 2003
First published: 2004
Editors: Guy B. Faguet
Dimensions: 254 x 178 x 29mm (L x W x T)
Format: Hardcover
Pages: 421
Edition: 2004 ed.
ISBN-13: 978-1-58829-099-1
Categories: Books > Medicine > Clinical & internal medicine > Haematology
Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Genetics (non-medical) > General
Promotions
LSN: 1-58829-099-9
Barcode: 9781588290991

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners